|
Aptilon Prices Offering of Common Shares
NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES
OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES
Montreal, Quebec, July 12, 2007 - Aptilon Corporation (“Aptilon” or the “Corporation”) (TSX-V: APZ), announced today that it has entered into an agency agreement (the "Agency Agreement") with Paradigm Capital Inc., as lead agent, and Loewen, Ondaatje, McCutcheon Limited. and Cormark Securities Inc. in respect of the offering of common shares contemplated by the preliminary short form prospectus filed on June 20, 2007. Under the terms of the Agency Agreement, the agents will offer up to 25,000,000 common shares at a price of $0.40 per common share. The agents have been granted an over-allotment option for a period of 30 days following the closing of the Offering to arrange for the sale of up to an additional 3,750,000 common shares at the issue price.
Aptilon anticipates filing a final prospectus on July 13, 2007. Closing is currently expected to occur on or about July 19. Aptilon expects to use the proceeds of the Offering for working capital and for general corporate purposes, including acquisitions. The Company has no present agreements or commitments with respect to any acquisitions. The Offering is subject to regulatory approval including approval of the TSX Venture Exchange.
This press release is not an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech, and medical device companies to effectively reach and interact with physicians via the Internet through its innovative live video detailing (with company reps), e-detailing, e-sampling, peer selling, and other educational content programs. Leading healthcare companies have adopted Aptilon's "Sales Force of the Future" model, driving tens of thousands of high-quality rep- physician interactions averaging 8 to 10 minutes in length. Aptilon provides the necessary infrastructure for sales representatives to build physician awareness, understanding, and preference during all stages of a product life cycle, from pre-launch education through to end-stage support. For more information, visit www.aptilon.com.
###
|
